Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2003
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003102579A2 Method of screening groups of radioactive molecules and applications thereof
12/11/2003WO2003102180A1 NOVEL PEPTIDES HAVING cAMP PRODUCING ACTIVITY
12/11/2003WO2003102138A2 Elongase genes and uses thereof
12/11/2003WO2003102135A2 Control sequences of the human corin gene
12/11/2003WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003WO2003101990A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
12/11/2003WO2003101989A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
12/11/2003WO2003101983A1 Tetrahydropyran derivative
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003101965A1 Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use
12/11/2003WO2003101962A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2003WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003WO2003101957A1 New salts
12/11/2003WO2003101956A1 Pharmaceutical combination
12/11/2003WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003WO2003101493A1 Intravenous composition, process for producing the same and preparation thereof
12/11/2003WO2003101491A1 PREVENTIVES AND/OR REMEDIES FOR SUBJECTS WITH THE EXPRESSION OR ACTIVATION OF Her2 AND/OR EGFR
12/11/2003WO2003101490A1 Drug composition containing calcium channel antagonist
12/11/2003WO2003101456A1 Use of compounds that stimulate cgmp
12/11/2003WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/11/2003WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris
12/11/2003WO2003101448A1 The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
12/11/2003WO2003101447A1 Ischemic reperfusion arrhythmia inhibitors
12/11/2003WO2003101424A1 Modified release pharmaceutical formulation
12/11/2003WO2003101423A1 Immediate release pharmaceutical formulation
12/11/2003WO2003101374A2 Use of new etonogestrel esters
12/11/2003WO2003101201A1 Intramyocardial injection of autologous bone marrow
12/11/2003WO2003080566A3 Hif hydroxylase inhibitors
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003053163A3 Salt composition with low sodium chloride and high organic potassium salt content and uses thereof
12/11/2003WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/11/2003WO2003038037A3 Glycogen synthase kinase function in endothelial cells
12/11/2003WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
12/11/2003WO2003037166A3 Devices and methods for the restoration of a spinal disc
12/11/2003WO2003032912A3 Treatment of cns disorders using cns target modulators
12/11/2003WO2003027292A3 Regulation of human fatty acid-coa ligase-like enzyme
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2003026579A3 Combination therapies for immune mediated diseases
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003WO2003011226A3 Products and drug delivery vehicles
12/11/2003WO2003004460A3 Succinic acid derivatives
12/11/2003WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds
12/11/2003WO2002100825A3 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/11/2003WO2002094176A3 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments
12/11/2003WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
12/11/2003WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003WO2002062778A3 Anti-thrombotic compounds, production and use thereof as medicaments
12/11/2003US20030229220 Oligomer phosphoramidite compositions and processes for synthesizing the same
12/11/2003US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders
12/11/2003US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/11/2003US20030229118 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229108 Angiogenesis inhibitors; antitumor agents, anticancer agents
12/11/2003US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents
12/11/2003US20030229095 Sexual disorders
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229086 Central nervous system disorders; side effect reduction
12/11/2003US20030229084 Osteoporosis; antiarthritic agents
12/11/2003US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/11/2003US20030229080 Cardiovascular disorders; sexual disorders
12/11/2003US20030229074 Metabolism; eating disorders; sexual disorders
12/11/2003US20030229070 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonist and alpha-1-blocking action
12/11/2003US20030229068 Controlling apoptosis, cell proliferation; strokes; anticancer agents; central nervous system disorders
12/11/2003US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229064 Method of treating cancer using dithiocarbamate derivatives
12/11/2003US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders
12/11/2003US20030229047 Liquid formulation of decitabine and use of the same
12/11/2003US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
12/11/2003US20030228371 Anti-infarction molecules
12/11/2003US20030228365 Pharmaceutical formulation
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003US20030228354 Drug in pressure sensitive adhesive
12/11/2003US20030228295 Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
12/11/2003US20030228273 Novel high viscosity embolizing compositions comprising prepolymers
12/11/2003CA2487905A1 Use of cgmp - stimulating compounds
12/11/2003CA2487679A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003CA2487509A1 New salts
12/11/2003CA2487410A1 Intramyocardial injection of autologous bone marrow
12/11/2003CA2487293A1 Use of new etonogestrel esters
12/11/2003CA2487024A1 Control sequences of the human corin gene
12/11/2003CA2486933A1 Tetrahydropyran derivative
12/11/2003CA2486911A1 Method of screening groups of radioactive molecules and applications thereof
12/11/2003CA2486530A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003CA2486191A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
12/11/2003CA2486174A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003CA2486110A1 Pharmaceutical combination
12/11/2003CA2485871A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2003CA2485533A1 Immediate release pharmaceutical formulation
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
1 ... 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 ... 1595